Baseline physical activity is associated with reduced mortality and disease outcomes in COVID‐19: A systematic review and meta‐analysisReview Published on 2022-04-132023-06-16 Journal: Reviews in Medical Virology [Category] MERS, [키워드] COVID‐19 exercise meta‐analysis physical activity [DOI] 10.1002/rmv.2349 PMC 바로가기 [Article Type] Review
Computed tomography‐defined body composition as prognostic markers for unfavourable outcomes and in‐hospital mortality in coronavirus disease 2019Original Article Published on 2022-01-122022-10-29 Journal: Journal of Cachexia, Sarcopenia and Muscle [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] 95% CI age Analysis association body composition clinically Computed tomography confidence interval coronavirus disease COVID‐19 COVID‐19 patient COVID‐19 database disorder Factor fat Implications men meta‐analysis Mortality Odds ratio outcome parameter Patient patients Predictive Prevalence prognostic prognostic biomarker Prognostic marker Result sarcopenia screened Skeletal muscle systematic review Univariate analysis visceral Visceral fat area women [DOI] 10.1002/jcsm.12868 PMC 바로가기 [Article Type] Original Article
Meta‐analysis of arbidol versus lopinavir/ritonavir in the treatment of coronavirus disease 2019Meta-Analysis Published on 2021-12-062022-10-04 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 치료제, [키워드] acute respiratory syndrome Adverse reaction Arbidol Chest computed tomography China Cochrane Library Controlled trial coronavirus coronavirus disease Coronavirus disease 2019 cough COVID‐19 database Day Efficacy and safety evaluate incidence indicated Lopinavir/ritonavir meta‐analysis Mortality multicenter network no difference nucleic acid objective patients Randomized Result SARS‐CoV‐2 searched systematic review Treatment two groups VIP was used [DOI] 10.1002/jmv.27481 PMC 바로가기 [Article Type] Meta-Analysis
The likelihood of severe COVID‐19 outcomes among PLHIV with various comorbidities: a comparative frequentist and Bayesian meta‐analysis approachReview Published on 2021-11-192022-10-31 Journal: Journal of the International AIDS Society [Category] COVID-19, MERS, SARS, [키워드] adjusted approach Bayesian Bayesian analysis cardiovascular disease Chronic kidney disease clinical Comorbidities Comorbidity conducted Corona virus COVID‐19 COVID‐19 data extraction develop diabete diabetes Effect Evidence exclusion Health heterogenous higher risk HIV HIV infection hypertension likelihood meta‐analysis nine Odds ratio outcome outcomes people with HIV Perspective PLHIV Population Predictive produced provided Respiratory disease Result risk robust SARS‐CoV‐2 virus Seven vaccination Web of Science with HIV [DOI] 10.1002/jia2.25841 PMC 바로가기 [Article Type] Review
Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta‐analysisResearch Article Published on 2021-10-162022-10-31 Journal: Cancer Medicine [Category] COVID-19, MERS, [키워드] addition Analysis benefit collaboration collected comparable COVID‐19 COVID‐19 deficiency demonstrated Denmark effective Efficacy Efficacy and safety evaluate Evidence HCC hepatocellular Hepatocellular carcinoma hyperthermia hyperthermia ablation incidence indicated large sample limitation Liver damage material meta‐analysis monotherapy no significant difference Patient patients performed produced reduced regimen Research Result Safe SARS‐CoV‐2 significantly surgical resection survival systematic review TACE the patient therapy Toxicity transarterial chemoembolization was performed [DOI] 10.1002/cam4.4350 PMC 바로가기 [Article Type] Research Article
Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID‐19 patients: A systematic review and meta‐analysis코로나19 환자에서 토실리주맙, 사릴루맙, 아나킨라의 효능 및 2차 감염 위험: 체계적 고찰 및 메타분석Review Published on 2021-09-242022-09-12 Journal: Reviews in Medical Virology [Category] COVID19(2023년), SARS, 진단, [키워드] 95% confidence interval addition Anakinra Analysis Clinical efficacy controls coronavirus disease Coronavirus disease 2019 COVID‐19 COVID‐19 patient COVID‐19 patients COVID‐19 decreased mortality Efficacy fungal had no Immunosuppressant immunosuppressants Immunotherapy increased risk Infection infection risk medRxiv meta‐analysis no effect Odds ratio pandemic progresses pathophysiology Patient patients risk sarilumab searched Secondary infection secondary infections selected significantly significantly increased subgroups systematic review therapy Tocilizumab tocilizumab therapy Treatment Web of Science [DOI] 10.1002/rmv.2295 PMC 바로가기 [Article Type] Review
Chinese herbal medicine (“3 medicines and 3 formulations”) for COVID ‐19: rapid systematic review and meta‐analysisCOVID -19의 중국 약초 (“3 개의 의약품 및 3 개의 제형”) : 빠른 체계적인 검토 및 메타 분석Review Published on 2021-09-162022-08-31 Journal: Journal of Evaluation in Clinical Practice [Category] COVID19(2023년), MERS, SARS, 임상, 치료제, [키워드] alleviate Alter article Baidu Chest CT Chinese clinical trial registries clinical trial registry CNKI COVID COVID‐19 COVID‐19 demonstrated disease severity effective evaluate Evidence Final groups Herbal herbal medicine Impact inclusion criteria Laboratory Manifestations Medicine meta‐analysis methodological limitations outcome outcomes participant Primary outcome random effect randomized trial RCT RCTs reported required Result retrospective searched secondary secondary outcome Secondary outcomes severity statistically significant Support Symptom Symptoms systematic review tested Treatment variable was performed [DOI] 10.1111/jep.13614 PMC 바로가기 [Article Type] Review
Effects of COVID‐19 lockdown on eating disorders and obesity: A systematic review and meta‐analysisReview Published on 2021-08-302022-10-31 Journal: European eating disorders review : the journal of the Eating Disorders [Category] Coronavirus, MERS, SARS, [키워드] Analysis anorexia Anxiety association Body carried changes in consequence COVID‐19 COVID‐19 database Depression Deterioration disorder distress eating eating disorders Effect examined Factor female groups identify inclusion criteria index individual lockdown longitudinal study majority mass measure mental health meta‐analysis no significant difference obesity objective participant Prevalence Psychological distress Quantitative reported Result suggested Symptom symptomatic Symptoms systematic review worsening [DOI] 10.1002/erv.2861 PMC 바로가기 [Article Type] Review
Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis코로나바이러스 2019(COVID-19)의 중증 질환 및 사망률과 관련된 심장 바이오마커, 심장 손상 및 동반 질환: 체계적인 검토 및 메타 분석Review Published on 2021-08-182022-09-10 Journal: Immunity, Inflammation and Disease [Category] MERS, SARS, 바이오마커, [키워드] 95% CI Acute cardiac injury acute myocardial injury Biomarker Biomarkers cardiac Cardiac biomarkers cardiac injury cardiovascular disease certainty Clinical research clinical trial clinical trials CNKI Cochrane Library Comorbidities Comorbidity coronavirus disease correlation COVID‐19 COVID‐19 patients COVID‐19 creatine creatine kinase Critical event Evidence except for groups help hypertension IMPROVE Injury Laboratory laboratory parameter Laboratory parameters Lactate lactate dehydrogenase LDH mean difference measure medRxiv meta‐analysis Mortality MOST myocardial injury Myoglobin no difference NT‐proBNP Odds ratio outcome outcome measures Patient patients peptide pool Relative risk Research Result risk SARS‐CoV‐2 sensitivity Serum level severe group severity SinoMed SMD systematic review systemically TnI total sample size Treatment troponin I VIP was performed was related Web of Science [DOI] 10.1002/iid3.471 PMC 바로가기 [Article Type] Review
Clinical significance of prognostic nutrition index in hospitalized patients with COVID‐19: Results from single‐center experience with systematic review and meta‐analysisArticle Published on 2021-07-162023-06-17 Journal: Nutrition in clinical practice : official publicat [Category] MERS, SARS, [키워드] COVID‐19 Inflammation meta‐analysis Mortality patient outcomes risk indicators [DOI] 10.1002/ncp.10750 PMC 바로가기